Investigating imitation SWI chromatin remodeling complexes in mammalian tissue regeneration
研究哺乳动物组织再生中的仿 SWI 染色质重塑复合物
基本信息
- 批准号:10436812
- 负责人:
- 金额:$ 36.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATP HydrolysisBromodomainCRISPR screenChIP-seqChemicalsChromatin Remodeling FactorClinicalClinical Drug DevelopmentComplexDataDiseaseDrug TargetingEnzymesEpigenetic ProcessExcisionGenesGeneticGenetic TranscriptionGenetic TranslationGenomicsGoalsHealthHepatocyteHistonesHumanIn VitroInflammatory Bowel DiseasesIntestinal DiseasesIntestinesKnockout MiceLiverLiver CirrhosisLiver RegenerationLiver diseasesLong-Term EffectsMalignant NeoplasmsMammalsMediatingModelingMolecularMusNatural regenerationNewtsNucleosomesOperative Surgical ProceduresOutputPathway interactionsPharmacologyPhenotypeProtein BiosynthesisProteinsReaderRecoveryRibosomal DNARibosomal RNARoleSMARCA5 geneSWI/SNF Family ComplexSystemTestingTissuesZebrafishchromatin remodelinggenome-widein vivoinhibitormurine colitisorgan regenerationregenerativeregenerative therapysmall moleculesmall molecule inhibitortherapeutic targettissue regenerationvalidation studies
项目摘要
PROJECT SUMMARY
The potent regenerative capabilities of planaria, newts, and zebrafish are largely lost in mammals, an observation
that has a tangible impact on human health. Compromised tissue regeneration likely contributes to disorders
such as liver cirrhosis or inflammatory bowel diseases (IBD). Limited regeneration in liver disease settings can
also preclude the ability to perform large surgical resections for cancer. The relative lack of regenerative
therapies could in part be because discovering new targets is difficult and is dependent on in vivo systems that
cannot be replicated in the culture dish. To identify new pathways that can be targeted to enhance regeneration,
we established an in vivo CRISPR-Cas9 screening platform to evaluate genes in the mouse liver. Using this
high-throughput system, we assessed the impact of 152 genes encoding epigenetic machines such as histone
readers, writers, and erasers [2]. This identified two imitation SWI/SNF (ISWI) chromatin remodeling complex
subunits encoded by Baz2a and Baz2b, genes that were not previously known to regulate regeneration. The
interaction between BAZ2 proteins with the SMARCA5 enzyme defines the nucleolar remodeling complex
(NoRC), one of five subtypes of ISWI complexes that uses ATP hydrolysis to remodel nucleosomes, particularly
at ribosomal DNA (rDNA) loci [3]. Our validation studies showed that in vivo Cas9 deletion of either Baz2a or
Baz2b increased liver regeneration in a hepatocyte repopulation model. Similarly, chemical inhibition of BAZ2A
and BAZ2B using the specific bromodomain inhibitor GSK2801 resulted in increased liver regeneration [4].
Moreover, we also found that GSK2801 could promote intestinal recovery in a mouse model of colitis. These
data suggest that BAZ2 containing ISWI/NoRC chromatin remodeling complexes are important for organ
regeneration and promising therapeutic targets for multiple diseases. Our central hypothesis is that the imitation
SWI components BAZ2A and BAZ2B limit efficient tissue regeneration by restricting increases in protein
synthesis via suppression of rRNA transcription. We will test different aspects of this hypothesis by validating
Baz2a and Baz2b genes as bona fide regeneration regulators (Aim 1), by understanding the global epigenetic
activities of BAZ2 containing complexes (Aim 2), and by determining if increased protein synthesis is a key
mechanism by which BAZ2 inhibition promotes regeneration (Aim 3). This project will define the regenerative
phenotypes and molecular mechanisms associated with ISWI chromatin remodeling. Our studies will facilitate
clinical drug development of small molecule inhibitors of BAZ2 proteins for use in enhancing tissue regeneration
in the liver and intestine.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hao Zhu其他文献
Hao Zhu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hao Zhu', 18)}}的其他基金
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10940417 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10675944 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Virtual nanostructure simulation (VINAS) portal
虚拟纳米结构模拟 (VINAS) 门户
- 批准号:
10567076 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
确定慢性 ETOH 如何影响肝细胞亚群的再生活动
- 批准号:
10297361 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
确定慢性 ETOH 如何影响肝细胞亚群的再生活动
- 批准号:
10458730 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:
Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations
确定慢性 ETOH 如何影响肝细胞亚群的再生活动
- 批准号:
10616522 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:
Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations
通过了解肝细胞亚群的恶性潜能和生物学来改善肝细胞癌小鼠模型
- 批准号:
10610474 - 财政年份:2020
- 资助金额:
$ 36.9万 - 项目类别:
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10350701 - 财政年份:2020
- 资助金额:
$ 36.9万 - 项目类别:
Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations
通过了解肝细胞亚群的恶性潜能和生物学来改善肝细胞癌小鼠模型
- 批准号:
10172879 - 财政年份:2020
- 资助金额:
$ 36.9万 - 项目类别:
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for Hepatotoxicity
机制驱动的肝毒性虚拟不良结果途径建模
- 批准号:
10166848 - 财政年份:2020
- 资助金额:
$ 36.9万 - 项目类别:
相似国自然基金
BET-Bromodomain小分子抑制剂和BET蛋白降解剂的设计合成及其表观遗传学性质研究
- 批准号:81673295
- 批准年份:2016
- 资助金额:59.0 万元
- 项目类别:面上项目
新型BET Bromodomain抑制剂治疗多发性硬化炎症反应的机制研究
- 批准号:81601409
- 批准年份:2016
- 资助金额:17.5 万元
- 项目类别:青年科学基金项目
基于片段的新型BET Bromodomain小分子抑制剂的设计、合成与生物活性研究
- 批准号:81473077
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
新型琥珀酰化、肉豆蔻酰化转移酶及其Bromodomain的发现
- 批准号:21302027
- 批准年份:2013
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于PCAF Bromodomain三维结构的抗艾滋病药物的设计与合成
- 批准号:30572234
- 批准年份:2005
- 资助金额:31.0 万元
- 项目类别:面上项目
酿酒酵母含Bromodomain转录因子Bdf1p在高盐胁迫反应中调控机制的研究
- 批准号:30570031
- 批准年份:2005
- 资助金额:26.0 万元
- 项目类别:面上项目
新bromodomain基因BRD7参与鼻咽癌细胞周期调控的机制研究
- 批准号:30400238
- 批准年份:2004
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
一个新的bromodomain基因的功能研究
- 批准号:30200135
- 批准年份:2002
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
- 批准号:
10577265 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
PBRM1 bromodomain missense mutations in ccRCC vascular signaling
ccRCC 血管信号传导中的 PBRM1 溴结构域错义突变
- 批准号:
10604440 - 财政年份:2023
- 资助金额:
$ 36.9万 - 项目类别:
Inhibition of CBP/p300 bromodomain activity increases chemosensitivity of p53 mutant colorectal cancers through inhibiting p53 aggregation
抑制 CBP/p300 溴结构域活性通过抑制 p53 聚集增加 p53 突变结直肠癌的化疗敏感性
- 批准号:
472399 - 财政年份:2022
- 资助金额:
$ 36.9万 - 项目类别:
Operating Grants
Characterization of the scaffolding roles of bromodomain containing proteins at the level of chromatin
含溴结构域蛋白在染色质水平上的支架作用表征
- 批准号:
RGPIN-2017-06124 - 财政年份:2022
- 资助金额:
$ 36.9万 - 项目类别:
Discovery Grants Program - Individual
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
胰腺癌中 BET 溴结构域蛋白和 MNK 激酶的共同靶向
- 批准号:
10338560 - 财政年份:2022
- 资助金额:
$ 36.9万 - 项目类别:
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
胰腺癌中 BET 溴结构域蛋白和 MNK 激酶的共同靶向
- 批准号:
10533366 - 财政年份:2022
- 资助金额:
$ 36.9万 - 项目类别:
Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis
含溴结构域蛋白 4 在促纤维化基因表达和肺纤维化中的作用
- 批准号:
10318204 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:
Investigating the role of bromodomain-containing proteins in the production of viable spermatozoa and male fertility
研究含溴结构域蛋白在活精子产生和男性生育能力中的作用
- 批准号:
10157200 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:
Investigating the role of bromodomain-containing proteins in the production of viable spermatozoa and male fertility
研究含溴结构域蛋白在活精子产生和男性生育能力中的作用
- 批准号:
10398876 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:
Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis
含溴结构域蛋白 4 在促纤维化基因表达和肺纤维化中的作用
- 批准号:
10556325 - 财政年份:2021
- 资助金额:
$ 36.9万 - 项目类别:














{{item.name}}会员




